Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance.
about
Tolerance to ischemia - an increasingly complex biologyImmune mechanisms in cerebral ischemic toleranceEpigenetics and therapeutic targets mediating neuroprotectionRepressor element-1 silencing transcription factor (REST)-dependent epigenetic remodeling is critical to ischemia-induced neuronal deathEnhanced hypoxic preconditioning by isoflurane: signaling gene expression and requirement of intracellular Ca2+ and inositol triphosphate receptorsEpigenetics and the environment: in search of the "toleroasome" vital to execution of ischemic preconditioning.Retinal proteomic changes under different ischemic conditions - implication of an epigenetic regulatory mechanismStroke research at a crossroad: asking the brain for directionsBmi1 confers resistance to oxidative stress on hematopoietic stem cellsFunctional up-regulation of endopeptidase neurolysin during post-acute and early recovery phases of experimental stroke in mouse brain.Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.Remote limb ischemic conditioning enhances motor learning in healthy humans.Reprogramming the response to stroke by preconditioningNeuroprotective actions of estradiol and novel estrogen analogs in ischemia: translational implicationsExtending injury- and disease-resistant CNS phenotypes by repetitive epigenetic conditioning.Epigenetic mechanisms of neuroplasticity and the implications for stroke recovery.HIF-1α Mediates Isoflurane-Induced Vascular Protection in Subarachnoid HemorrhagemiRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132Dynamic changes in DNA methylation in ischemic toleranceNascent proteomes of ischemic-injured and ischemic-tolerant neuronal cellsPolycomb-dependent repression of the potassium channel-encoding gene KCNA5 promotes cancer cell survival under conditions of stressCan genes modify stroke outcome and by what mechanisms?Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death.Method parameters' impact on mortality and variability in mouse stroke experiments: a meta-analysis.Proteomic analysis of an unculturable bacterial endosymbiont (Blochmannia) reveals high abundance of chaperonins and biosynthetic enzymesA critical review of mechanisms regulating remote preconditioning-induced brain protection.Epigenetic modulation of gene expression governs the brain's response to injuryChromatin-modifying agents for epigenetic reprogramming and endogenous neural stem cell-mediated repair in stroke.Biological networks in ischemic tolerance - rethinking the approach to clinical conditioningNascent proteomes in peripheral blood mononuclear cells as a novel source for biomarker discovery in human stroke.Ischemic tolerance in the brain: endogenous adaptive machinery against ischemic stress.The application of quantification techniques in proteomics for biomedical research.Molecular targets underlying SUMO-mediated neuroprotection in brain ischemia.The epigenetics of stroke recovery and rehabilitation: from polycomb to histone deacetylases.NRSF: an angel or a devil in neurogenesis and neurological diseases.Cerebral Ischemic Preconditioning: the Road So Far….Chromatin Changes Associated with Neuronal Maintenance and Their Pharmacological Application.The Emerging Role of Epigenetics in Cerebral Ischemia.Proteomic Analysis After Status Epilepticus Identifies UCHL1 as Protective Against Hippocampal Injury.Proteomics in stroke research: potentials of the nascent proteomics.
P2860
Q26851243-1EC31045-EFAC-4A55-B753-5CB5E617856BQ27022067-4A6C3609-70D9-4DD6-A350-5364AA092A84Q28080633-96C676D5-F6B2-4CE8-A311-120DAB79C9BEQ28260806-6FF9E668-1656-4D44-A93F-0A0CC7DEE450Q28581695-B56C30AA-7B19-4A64-9425-F6DAEA840B87Q33693885-636DBD08-E615-4AC1-BA3F-38DA68D2549AQ34080362-2B48F338-D81A-4383-9F27-CA07FDADBDAEQ34227730-BDBE0DD0-AAB4-4DEA-8399-E9BD3696340EQ34273512-876875EF-9A11-4455-98DE-AD1A0FEA85A3Q34380550-CFAD07C9-E671-4DD3-8C8E-01B7014101C7Q34390785-C471AA7F-325F-4B1C-836F-B72952EADB15Q34471406-D63F6167-20A0-4255-AC46-B10C57AC84A7Q34555863-373C870C-4F36-47ED-B629-A6F82E07EDFBQ34827433-EA76327D-A0D9-40AF-82AE-E5530698598FQ35135740-89E666FA-941C-47A5-830D-710FF89A46BCQ35220512-1BBC4ECC-32BF-4B28-83AE-E244F3F8F9B1Q35469534-CFD446DE-E0E8-431A-9997-EA622F9050EAQ35475193-5288D7AA-7F22-4AC1-B620-D7421B43D5A2Q35609509-44A8C657-2CE6-4A17-B66B-0F8E5A1A19A7Q35644876-0FC39FCE-2425-40A3-9328-0DE8C7734D57Q35672183-F42FD4A2-39F3-4F8D-9E72-2B6BCB721ECFQ35765612-ACE9D3D6-933A-4BB1-85F7-50FF9B78E930Q36361562-D0754DE8-001E-41C0-85BA-4C02B749CA7EQ36579398-63A220EA-C2B9-4BAB-93CE-EDF192F52CD8Q36690689-826B9E26-D9A7-4FF6-9FA7-A4DE733F7A1BQ36752376-8CB17AA6-C59F-4651-89E5-2BF75574B4F7Q36995424-54A40587-8CB1-47B0-9D9E-5129F6D47047Q37151715-B13F120D-5C87-4DA0-8DDE-4C87AF08C6A5Q37291743-F76F81A5-6CCE-44D8-BDCC-731EA00E6F07Q37712409-F1DC6102-F188-4699-9855-92AB585BEA7EQ37981130-EF48E238-7015-4139-9846-5658463EC6A1Q38030883-85BBAAA0-B812-48D0-B700-EC1DAED72DBBQ38115818-35C11784-B658-4615-8DC1-F50E75B55F27Q38149089-A8CBC727-6034-4147-BAA9-22FBDC13DAC6Q38283875-4B22B055-0D33-4585-881C-5267E2B4CFC9Q38529630-0CB6FAF4-C22D-499E-BCEF-210B8748D347Q38676090-922F4E3B-DBF0-44A9-9C0C-DB5049891581Q38740709-1FC33D62-352D-4A34-AD04-3A7AF1981DD6Q38843289-0C7EB4EF-FA24-43B9-AD48-3DE03F7F6488Q38901180-0E989D80-8B88-43DB-9E55-05B3B0384B11
P2860
Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance.
@en
Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance.
@nl
type
label
Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance.
@en
Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance.
@nl
prefLabel
Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance.
@en
Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance.
@nl
P2093
P2860
P1433
P1476
Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance.
@en
P2093
Chelsea Piper
Cheri Stowell
James Langridge
Jing-quan Lan
Julie Saugstad
Martha Stapels
Minghua Li
Roger P Simon
Scott Geromanos
P2860
P356
10.1126/SCISIGNAL.2000502
P577
2010-03-02T00:00:00Z